ImmunityBio, Inc. Completes Enrollment in Pivotal Randomized Trial Evaluating ANKTIVA®? Plus BCG Versus BCG Alone in BCG-Naive Non-Muscle Invasive Bladder Cancer Carcinoma in Situ
ImmunityBio, Inc. Completes Enrollment in Pivotal Randomized …
1 month ago
marketscreener.com
Qualified Patients for Cell Therapy - Clinical Trial Immunotherapies
Qualified Patients for Cell Therapy - Clinical Trial Immunotherapies
Oct 15, 2024
immunitybio.com
ImmunityBio, Inc. annonce la réalisation d'un financement en actions de 80 millions de dollars auprès de plusieurs investisseurs institutionnels
ImmunityBio, Inc. annonce la réalisation d'un financement en ac…
8 months ago
zonebourse.com
ImmunityBio, Inc. Provides Regulatory Update on Anticipated FDA Submissions in 2025 Following Meeting with the Agency
ImmunityBio, Inc. Provides Regulatory Update on Anticipated …
Jan 15, 2025
marketscreener.com
ImmunityBio reported that median overall survival has not yet been reached in patients with recurrent or progressive glioblastoma treated with a chemo-free ANKTIVA® CAR-NK-based regimen. As recent American Cancer Society data shows that brain cancer is now the third leading cause of cancer-related death among adults ages 20–49, these findings underscore the urgency of continued innovation in this disease. Read more: https://immunitybio.com/immunitybio-reports-median-overall-survival-not-yet-reac
0:15
ImmunityBio reported that median overall survival has not yet been r…
375 views2 months ago
FacebookImmunityBio
🧬ImmunityBio Mystery: Is the Surge Real or a Trap? Profit Strategy #IBRX
3:00
🧬ImmunityBio Mystery: Is the Surge Real or a Trap? Profit Strategy #IB…
3 views2 months ago
YouTubeMoonShot Project
Anktiva, according to its ImmunityBio, is the first FDA-approved immunotherapy that activates what’s called a natural killer cell to target and kill non-muscle-invasive bladder cancer cells. More: https://www.newsnationnow.com/health/newsnation-special-killing-cancer-treatment-soon-shiong/ | NewsNation
5:02
Anktiva, according to its ImmunityBio, is the first FDA-appr…
1.3M views4 months ago
FacebookNewsNation
Immunotherapy and Cell Therapy Platforms - Therapies for Cancer
9 months ago
immunitybio.com
13:25
Immunitybio Inc. 2025 annual report
4 views1 month ago
YouTubeThe Financial Report Guru
0:05
We've announced that the U.S. Food and Drug Administration (FDA) ha…
2K views10 months ago
FacebookImmunityBio
0:14
ImmunityBio, Inc. on Instagram: "At ImmunityBio, our pipeline continu…
1.2K views2 months ago
Instagramimmunitybio
0:25
Introducing Patrick Soon Shiong: The Secret Billionaire Who Contro…
223 views7 months ago
YouTubeInvest With Olivier
8:06
ImmunityBio (IBRX): Explosive ANKTIVA growth, rising oncology …
1K views4 months ago
YouTubeMr.Stockxy
6:39
ImmunityBio 2026 Commercial Analysis and FDA Regulatory Imp…
274 views2 weeks ago
YouTubeMarket Pulse Report
12:02
ImmunityBio’s ANKTIVA & FDA Expanded Access: Transforming …
3.3K views10 months ago
YouTubepharmaphorum media limited
4:31
ImmunityBio's bladder cancer therapy wins FDA approval
Apr 23, 2024
Yahoo
17:59
ImmunityBio Deep Dive: The TRUTH About the $IBRX Biotech Boom
720 views1 month ago
YouTubestockexplorers
Current Future Role of Anktiva (N-803): Dr. Patrick Soon-Shiong | Im…
29.9K views2 months ago
linkedin.com
16:40
ImmunityBio (IBRX) From Bladder Cancer to Lung Cancer: The Expa…
1.6K viewsOct 27, 2024
YouTubeMr.Stockxy
56:55
Commercial Readiness with ImmunityBio's Bobby Reddy, M.D.
3.8K viewsApr 15, 2024
YouTubeLife Science Connect
2:40
ImmunityBio’s Pipeline Is Loaded - And These Catalysts Could Send I…
463 views4 months ago
YouTubeInvest With Olivier
11:36
IBRX ImmunityBio Stock Analysis: Friday Predicted Opening Price & …
444 views2 months ago
YouTubeStockInvest.us
0:30
ImmunityBio (IBRX): The Transformation That Could Re-Rat…
390 views1 month ago
YouTubeInvest With Olivier
3:27
Why Investors Will Pump ImmunityBio Stock? IBRX STOCK …
287 views2 weeks ago
YouTubeKosumvi
6:12
The Secret Biotech Billionaire Behind ImmunityBio (IBRX) Revea…
1K views7 months ago
YouTubeInvest With Olivier
6:41
[FullVer] ImmunityBio Mystery: Why Did the FDA Reject ANKTIVA’s La…
1.1K views6 months ago
YouTube김박사 월드
4:07
How I Bought ImmunityBio (IBRX) at $1.34
668 views1 month ago
YouTubeInvest With Olivier
10:01
$IBRX Stock Analysis ImmunityBio, Inc.#ImmunityBio #IBRX #Biotech
119 views8 months ago
YouTubeHisseseven
12:45
IBRX ImmunityBio Stock Analysis: Monday Predicted Opening Price …
383 views2 months ago
YouTubeStockInvest.us
3:49
ImmunityBio’s (IBRX) Biggest Strategic Shift Yet?
673 views1 month ago
YouTubeInvest With Olivier
See more videos
Static thumbnail place holder